NemaLife Files a Novel Gut Health Bioassay Patent to Aid the Discovery of Functional Ingredients
New provisional patent application for a rapid microfluidic in vivo assay enabling discovery of new gut health solutions for the functional
Preclinical discovery for R&D is slow, costly, and outdated.
​
We're here to change that.
We are changing the way the world thinks about the discovery and development of safe and effective ingredients.
NemaLife is a TechBio company accelerating the pace of ingredient discovery and development using proprietary high throughput technologies.
We partner with companies that care about delivering safe, healthy, and sustainable products by leveraging our innovative platforms to unlock transformative business potential.
Evaluating novel ingredients in mammals takes years and can cost millions, slowing down product development.
​
Our patented organism-on-chip technology reduces costs by 10x.
We help bring products to market 10x faster than traditional research and development methods.
​
Working with our partners, our platform has been validated with many ingredient classes, and several of their products are now entering clinical trials.
Our innovative team continually evolves our technology to develop custom R&D solutions for our partners.
Our AI-enabled platforms bring unprecedented scale and efficiency thanks to the combination of world-class AI and our patented microfluidic organism-on-chip platform.
Over 100 million mice are used annually to evaluate new product safety and efficacy. Our organism-on-chip technology reduces reliance on mammals, helping the world move towards cruelty-free products.
​
Taking proper care of mammals consumes significant energy and water resources. We see a future where most of the world’s ingredients will be evaluated sustainably - the NemaLife way.
55K+
Tonnes of CO2 Reduced
700K+
Mammals Saved
400+
Ingredients Tested
14B+
Watts of Energy Saved
1.3M+
Liters of Water Saved
Who We Work With
Great Companies Make Great Partners
Explore our Partnership Options
Discover IP-protected ingredients and generate validation data to move to clinical trials.
Develop and deploy AI-assisted microfluidic platforms that deliver category-defining strategic value.
Be the difference with us.